01/31/2026
Wall Street is already evaluating Medical Affairs.
Valuation Beyond the Molecule reveals how institutional investors use Medical Affairs signals to assess company stability, scientific maturity, and long term performance.
Michael S K Jeong MD, Portfolio Manager at White Manna Capital, explains which MA indicators influence market confidence and how external stakeholders judge organizations beyond internal metrics.
Interactive exchange at 3:15 PM with case specific discussion.
Medical Affairs is no longer internal facing. It is market facing.
Register https://hubs.ly/Q04161yQ0